Delivery Order SPE2DE24D0013-SPE2D625F1WBG
- Not listed
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded Cepheid Inc. a delivery order valued at $22,240 on September 9, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV). This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by September 16, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit...
- This delivery order, valued at $19,047.16, was awarded to Cepheid Inc. on August 13, 2025, by the Defense Logistics Agency (operating under the Medical Supply Chain program) for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract is a firm fixed-price arrangement with no set-aside designation and is scheduled for completion by August 20, 2025. Performance will take place at Cepheid's facility in Sunnyvale, California. Cepheid...
- This delivery order, awarded July 28, 2025, represents a $3,400 firm fixed-price contract between the Defense Logistics Agency's Medical Supply Chain division and Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California. The order is designated for respiratory pathogen testing, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection, with performance to be completed by August 4, 2025. No set-aside designation was applied to this procurement....
- This delivery order, valued at $6,800, was awarded to Cepheid Inc. on September 4, 2025, by the Medical Supply Chain, a defense-focused federal agency. The contract covers molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection, with performance to be completed at Cepheid's Sunnyvale, California facility by September 11, 2025. The award carries a firm fixed-price structure with no set-aside designation, indicating competitive procurement....
- The Defense Logistics Agency awarded a $40.8K delivery order (Contract 4569470191) to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for the supply of COVID-19/Flu/RSV testing solutions. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, carries no set-aside designation and represents part of Cepheid's broader supply relationship with the Defense Department's medical supply chain operations. Cepheid specializes in...
- This delivery order, awarded on September 9, 2025, represents a $41,490 firm fixed-price contract between the Defense Logistics Agency (Medical Supply Chain) and Cepheid Inc. for molecular diagnostic solutions. The contract, which runs through September 16, 2025, procures diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic systems, specializes in advanced infectious...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain program, awarded a $8,995.14 firm fixed-price delivery order to Cepheid Inc. on May 6, 2025, for molecular diagnostic solutions with an ultimate completion date of May 13, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, references testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV)—aligning with Cepheid's core diagnostic product offerings. The contract carries no set-aside...
- The U.S. Defense Logistics Agency, through the Medical Supply Chain division, awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This delivery order, issued on June 18, 2025, with an ultimate completion date of June 26, 2025, is designated as XPCOV2/FLU/RSV-10 and carries no set-aside designation. The delivery order addresses federal requirements for COVID-19, influenza, and respiratory syncytial virus...
- The Defense Logistics Agency issued a $34,223.80 firm fixed-price delivery order to Cepheid Inc. on September 15, 2025, for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic testing supplies and services. The contract, designated as XPCOV2/FLU/RSV-10, carries an ultimate completion date of September 22, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. This delivery order does not utilize a set-aside designation and represents a continuation of...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain function, awarded a $20.4K firm fixed-price delivery order to Cepheid Inc. on September 18, 2025, with a completion date of September 25, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) testing, with performance to be executed at Cepheid's facility in Sunnyvale, California. This award carries no set-aside...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F1WBGDelivery Order
This delivery order, valued at $40,800, was awarded to Cepheid Inc. on August 25, 2025, by the Defense Logistics Agency's Medical Supply Chain division for the provision of molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract carries a firm fixed-price structure with no set-aside designation and is scheduled for completion by September 2, 2025. Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular diagnostic systems and test kits, will perform the work at its headquarters location. This delivery order is issued under one of Cepheid's existing Indefinite Delivery Vehicle contracts, which enable continuous procurement of molecular diagnostic testing system reagents and assays to support federal healthcare operations. Cepheid has established itself as a key provider of molecular diagnostic solutions across multiple federal agencies, including the Department of Veterans Affairs, Indian Health Service, and Defense Logistics Agency. The company's core offerings include GeneXpert diagnostic systems, reagents, test kits, and maintenance services designed for detecting infectious diseases. The relatively short completion timeframe for this delivery order suggests the procurement is addressing an immediate operational need for COVID-19, influenza, and RSV diagnostic capabilities within the Defense Department's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.8k | 8/25/25 |